Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 3/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.33 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.33 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13857821 | 1.00 | SLC1A3 (0.34) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL4458615 | 0.82 | IDO1 (0.37) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL7375800 | 0.80 | IDO1 (0.36) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL7200966 | 0.78 | IDO1 (0.36) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL598028 | 0.77 | GRIK1 (0.36) | GRIK1GRIK2IDO1TDO2 | |
| SCHEMBL15156025 | 0.77 | IDO1 (0.35) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL7241021 | 0.77 | IDO1 (0.35) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL1614569 | 0.77 | IDO1 (0.35) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL686409 | 0.76 | IDO1 (0.33) | SLC1A3SLC1A2SLC1A1IDO1TDO2 | |
| SCHEMBL687402 | 0.76 | IDO1 (0.33) | SLC1A3SLC1A2SLC1A1IDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1929 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577575-B2 | Methods and compositions for promoting non-natural amino acid-containing protein production | AMBRX, INC. (US) | 2026-03-17 | — | — | US | claimed |
| EP-4689127-A1 | RF1 KO E. COLI STRAINS | Sutro Biopharma, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-12540197-B2 | Anti-tissue factor antibodies and antibody conjugates, compositions comprising anti-tissue factor antibodies or antibody conjugates, and methods of making and using anti-tissue factor antibodies and antibody conjugates | SUTRO BIOPHARMA, INC. (US) | 2026-02-03 | — | — | US | claimed |
| US-20250327074-A1 | THE RARE CODON RECODING PLATFORM FOR NONCANONICAL AMINO ACIDS INCORPORATION IN MAMMALIAN CELLS | SHAOXING INSTITUTE, ZHEJIANG UNIVERSITY (CN) | 2025-10-23 | — | — | US | claimed |
| US-20250325633-A1 | CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | Synthorx, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| US-20250325632-A1 | CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES | Synthorx, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| US-20250304723-A1 | MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | SUTRO BIOPHARMA, INC. | 2025-10-02 | — | — | US | claimed |
| US-12427201-B2 | Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates | SUTRO BIOPHARMA, INC. (US) | 2025-09-30 | — | — | US | claimed |
| US-12404512-B2 | Method for optimizing antibody expression | AMBRX, INC. (US) | 2025-09-02 | — | — | US | claimed |
| EP-3788149-B1 | A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION | AMBRX INC (US) | 2025-08-27 | — | — | EP | claimed |
| US-20050208536-A1 | Comprises ribonuclease barnase marker gene; libraries; drug resistance | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-09-22 | — | — | US | claimed |
| EP-1456360-A4 | METHODS AND COMPOSITION FOR THE PRODUCTION OF ORTHOGANAL TRNA-AMINOACYLTRNA SYNTHETASE PAIRS | SCRIPPS RESEARCH INST (US) | 2005-05-25 | — | — | EP | claimed |
| US-20050009049-A1 | Expanding the eukaryotic genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-01-13 | — | — | US | claimed |
| EP-1490483-A2 | IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDS | The Scripps Research Institute (US) | 2004-12-29 | — | — | EP | claimed |
| WO-2004094593-A2 | EXPANDING THE EUKARYOTIC GENETIC CODE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2004-11-04 | — | — | WO | claimed |
| EP-1456360-A2 | METHODS AND COMPOSITION FOR THE PRODUCTION OF ORTHOGANAL TRNA-AMINOACYLTRNA SYNTHETASE PAIRS | The Scripps Research Institute (US) | 2004-09-15 | — | — | EP | claimed |
| US-20030108885-A1 | Comprises ribonuclease barnase marker gene; recombination/genetic engineering; libraries; drug resistance | THE SCRIPPS RESEARCH INSTITUTE (US) | 2003-06-12 | — | — | US | claimed |
| US-20030082575-A1 | Translation system for use in the generation of protein containing adjusted amino acid sequences | THE SCRIPPS RESEARCH INSTITUTE (US) | 2003-05-01 | — | — | US | claimed |
| WO-2002086075-A2 | METHODS AND COMPOSITION FOR THE PRODUCTION OF ORTHOGANAL TRNA-AMINOACYLTRNA SYNTHETASE PAIRS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2002-10-31 | — | — | WO | claimed |
| WO-2002085923-A2 | IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2002-10-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325633-A1 | CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | IL2, IL2RA, IL15 | SLC1A3 3456/4885SLC1A2 2531/4885SLC1A1 3400/4885 |
| US-12427201-B2 | Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates | FOLR1, FOLR2, DHFR | SLC1A3 632/4885SLC1A2 792/4885SLC1A1 473/4885 |
| US-20250304723-A1 | MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | FCGR2A, FCGR3B, FCGR1A | SLC1A3 457/4885SLC1A2 1057/4885SLC1A1 643/4885 |
| US-20050009049-A1 | Expanding the eukaryotic genetic code | NSUN3, AARS1, TRMT1 | SLC1A3 684/4885SLC1A2 634/4885SLC1A1 468/4885 |
| US-12577575-B2 | Methods and compositions for promoting non-natural amino acid-containing protein production | AARS1, NSUN3, UPF1 | SLC1A3 873/4885SLC1A2 999/4885SLC1A1 823/4885 |
| US-20050208536-A1 | Comprises ribonuclease barnase marker gene; libraries; drug resistance | RNASEL, RNASEH1, RNASE1 | SLC1A3 1650/4885SLC1A2 1543/4885SLC1A1 1159/4885 |
| US-20250325632-A1 | CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES | IL2, IL2RA, IL36G | SLC1A3 4236/4885SLC1A2 3478/4885SLC1A1 3969/4885 |
| US-12540197-B2 | Anti-tissue factor antibodies and antibody conjugates, compositions comprising anti-tissue factor antibodies or antibody conjugates, and methods of making and using anti-tissue factor antibodies and antibody conjugates | VSIG8, F13B, HNRNPH3 | SLC1A3 1845/4885SLC1A2 2006/4885SLC1A1 1629/4885 |
| US-20030108885-A1 | Comprises ribonuclease barnase marker gene; recombination/genetic engineering; libraries; drug resistance | RNASEL, RNASEH1, RNASE1 | SLC1A3 2115/4885SLC1A2 1964/4885SLC1A1 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.